Literature DB >> 4218812

Cytostatic activity of chlamydocin, a rapidly inactivated cyclic tetrapeptide.

H Stähelin, A Trippmacher.   

Abstract

Mesh:

Substances:

Year:  1974        PMID: 4218812     DOI: 10.1016/0014-2964(74)90137-6

Source DB:  PubMed          Journal:  Eur J Cancer        ISSN: 0014-2964            Impact factor:   9.162


× No keyword cloud information.
  7 in total

1.  New antitumoral cyclopeptides.

Authors:  E Bernardi; J L Fauchère; G Atassi; P Viallefont; R Lazaro
Journal:  Amino Acids       Date:  1994-10       Impact factor: 3.520

2.  Enhanced toxicity of the immunosuppressant ovalicin upon application to the skin.

Authors:  H Stähelin
Journal:  Experientia       Date:  1988-07-15

3.  The history of cyclosporin A (Sandimmune) revisited: another point of view.

Authors:  H F Stähelin
Journal:  Experientia       Date:  1996-01-16

4.  Reciprocal biological activities of the cyclic tetrapeptides chlamydocin and HC-toxin.

Authors:  J D Walton; E D Earle; H Stähelin; A Grieder; A Hirota; A Suzuki
Journal:  Experientia       Date:  1985-03-15

Review 5.  Histone deacetylases (HDACs): characterization of the classical HDAC family.

Authors:  Annemieke J M de Ruijter; Albert H van Gennip; Huib N Caron; Stephan Kemp; André B P van Kuilenburg
Journal:  Biochem J       Date:  2003-03-15       Impact factor: 3.857

6.  Potent histone deacetylase inhibitors built from trichostatin A and cyclic tetrapeptide antibiotics including trapoxin.

Authors:  R Furumai; Y Komatsu; N Nishino; S Khochbin; M Yoshida; S Horinouchi
Journal:  Proc Natl Acad Sci U S A       Date:  2001-01-02       Impact factor: 11.205

7.  The reactivity and conformational control of cyclic tetrapeptides derived from aziridine-containing amino acids.

Authors:  Benjamin K W Chung; Christopher J White; Conor C G Scully; Andrei K Yudin
Journal:  Chem Sci       Date:  2016-06-30       Impact factor: 9.825

  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.